Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003
Published online before print September 4, 2003, doi: 10.1161/01.RES.0000093984.48643.D7
A more recent version of this article appeared on October 3, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/7/664    most recent
01.RES.0000093984.48643.D7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamakawa, M.
Right arrow Articles by Jiang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamakawa, M.
Right arrow Articles by Jiang, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DESFERRIOXAMINE
Related Collections
Right arrow Angiogenesis
Right arrow Gene expression

Submitted on April 11, 2003
Revised on July 11, 2003
Accepted on August 18, 2003

Hypoxia-Inducible Factor-1 Mediates Activation of Cultured Vascular Endothelial Cells by Inducing Multiple Angiogenic Factors

Midori Yamakawa ; Louis X. Liu ; Taro Date ; Adam J. Belanger ; Karen A. Vincent ; Geoffrey Y. Akita ; Takayuki Kuriyama ; Seng H. Cheng ; Richard J. Gregory ; and Canwen Jiang *

From Genzyme Corporation (M.Y., L.X.L., T.D., A.J.B., K.A.V., G.Y.A., S.H.C., R.J.G., C.J.), Framingham, Mass; and the Department of Respirology (T.K.), Graduate School of Medicine, Chiba University, Chiba, Japan.

* To whom correspondence should be addressed. E-mail: canwen.jiang{at}genzyme.com.

Hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of vascular endothelial growth factor (VEGF) and other hypoxia-responsive genes. Transgenic expression of a constitutively stable HIF-1{alpha} mutant increases the number of vascular vessels without vascular leakage, tissue edema, or inflammation. This study aimed to investigate the molecular basis by which HIF-1 mediates the angiogenic response to hypoxia. In primary human endothelial cells, hypoxia, desferrioxamine, or infection with Ad2/HIF-1{alpha}/VP16, an adenoviral vector encoding a constitutively stable hybrid form of HIF-1{alpha}, increased the mRNA and protein levels of VEGF, angiopoietin-2 (Ang-2), and angiopoietin-4 (Ang-4). Infection with Ad2/CMVEV (a control vector expressing no transgene) had no effect. Angiopoietin-1 (Ang-1) expression was not detected in human endothelial cells. Ang-4 was also induced by hypoxia or Ad2/HIF-1{alpha}/VP16 in human cardiac cells, whereas Ang-1 expression remained unchanged. Recombinant Ang-4 protein protected endothelial cells against serum starvation-induced apoptosis and increased cultured endothelial cell migration and tube formation. Ad2/HIF-1{alpha}/VP16 stimulated endothelial cell proliferation and tube formation. Hypoxia- or Ad2/HIF-1{alpha}/VP16-induced tube formation was significantly reduced by a Tie-2 inhibitor. These results suggest that HIF-1 mediates the angiogenic response to hypoxia by upregulating the expression of multiple angiogenic factors. Ang-4 can function similarly as Ang-1 and substitute for Ang-1 to participate in hypoxia-induced angiogenesis. Activation of the angiopoietin/Tie-2 system may play a role in the ability of HIF-1 to induce hypervascularity without excessive permeability.


Key words: hypoxia-inducible factor-1 • hypoxia • angiogenesis • angiopoietins • vascular endothelial growth factor




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Fasanaro, Y. D'Alessandra, V. Di Stefano, R. Melchionna, S. Romani, G. Pompilio, M. C. Capogrossi, and F. Martelli
MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3
J. Biol. Chem., June 6, 2008; 283(23): 15878 - 15883.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. T.M. Krishnan, C. Quattrini, M. Jeziorska, R. A. Malik, and G. Rayman
Neurovascular Factors in Wound Healing in the Foot Skin of Type 2 Diabetic Subjects
Diabetes Care, December 1, 2007; 30(12): 3058 - 3062.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Bateman, C. Tokunaga, T. Kareco, D. R. Dorscheid, and K. R. Walley
Myocardial hypoxia-inducible HIF-1{alpha}, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM-1 heterogeneity during endotoxemia
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H448 - H456.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A. M Abu El-Asrar, L. Missotten, and K. Geboes
Expression of hypoxia-inducible factor-1{alpha} and the protein products of its target genes in diabetic fibrovascular epiretinal membranes
Br. J. Ophthalmol., June 1, 2007; 91(6): 822 - 826.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. K.C. Ng, J. Wu, E. Chang, B.-y. Wang, R. Katzenberg-Clark, A. Ishii-Watabe, and J. P. Cooke
A Central Role for Nicotinic Cholinergic Regulation of Growth Factor-Induced Endothelial Cell Migration
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 106 - 112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. C. Schatteman, M. Dunnwald, and C. Jiao
Biology of bone marrow-derived endothelial cell precursors
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H1 - H18.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Takeda and G.-H. Fong
Prolyl Hydroxylase Domain 2 Protein Suppresses Hypoxia-Induced Endothelial Cell Proliferation
Hypertension, January 1, 2007; 49(1): 178 - 184.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. Schiekofer, I. Shiojima, K. Sato, G. Galasso, Y. Oshima, and K. Walsh
Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure
Physiol Genomics, October 11, 2006; 27(2): 156 - 170.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Zampino, M. Yuzhakova, J. Hansen, R. D. McKinney, P. H. Goldspink, D. L. Geenen, and P. M. Buttrick
Sex-related dimorphic response of HIF-1{alpha} expression in myocardial ischemia
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H957 - H964.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. M. Kim, K. E. Kim, G. Y. Koh, Y.-S. Ho, and K.-J. Lee
Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis.
Cancer Res., June 15, 2006; 66(12): 6167 - 6174.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Luo, C. Jiang, A. J. Belanger, G. Y. Akita, S. C. Wadsworth, R. J. Gregory, and K. A. Vincent
A Constitutively Active Hypoxia-Inducible Factor-1{alpha}/VP16 Hybrid Factor Activates Expression of the Human B-Type Natriuretic Peptide Gene
Mol. Pharmacol., June 1, 2006; 69(6): 1953 - 1962.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. P.J. Brindle, P. Saharinen, and K. Alitalo
Signaling and Functions of Angiopoietin-1 in Vascular Protection
Circ. Res., April 28, 2006; 98(8): 1014 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Glasker, J. Li, J. B. Xia, H. Okamoto, W. Zeng, R. R. Lonser, Z. Zhuang, E. H. Oldfield, and A. O. Vortmeyer
Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell.
Cancer Res., April 15, 2006; 66(8): 4167 - 4172.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Calvani, A. Rapisarda, B. Uranchimeg, R. H. Shoemaker, and G. Melillo
Hypoxic induction of an HIF-1{alpha}-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells
Blood, April 1, 2006; 107(7): 2705 - 2712.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. H. Licht, F. Muller-Holtkamp, I. Flamme, and G. Breier
Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development
Blood, January 15, 2006; 107(2): 584 - 590.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. Pi, G. Garin, L. Xie, Q. Zheng, H. Wei, J.-i. Abe, C. Yan, and B. C. Berk
BMK1/ERK5 Is a Novel Regulator of Angiogenesis by Destabilizing Hypoxia Inducible Factor 1{alpha}
Circ. Res., June 10, 2005; 96(11): 1145 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
B. Kaur, F. W. Khwaja, E. A. Severson, S. L. Matheny, D. J. Brat, and E. G. Van Meir
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
Neuro-oncol, April 1, 2005; 7(2): 134 - 153.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
F. Tertemiz, U. A. Kayisli, A. Arici, and R. Demir
Apoptosis Contributes to Vascular Lumen Formation and Vascular Branching in Human Placental Vasculogenesis
Biol Reprod, March 1, 2005; 72(3): 727 - 735.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Date, S. Mochizuki, A. J. Belanger, M. Yamakawa, Z. Luo, K. A. Vincent, S. H. Cheng, R. J. Gregory, and C. Jiang
Expression of constitutively stable hybrid hypoxia-inducible factor-1{alpha} protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury
Am J Physiol Cell Physiol, February 1, 2005; 288(2): C314 - C320.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. J. Manalo, A. Rowan, T. Lavoie, L. Natarajan, B. D. Kelly, S. Q. Ye, J. G. N. Garcia, and G. L. Semenza
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
Blood, January 15, 2005; 105(2): 659 - 669.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Frantz, K. A. Vincent, O. Feron, and R. A. Kelly
Innate Immunity and Angiogenesis
Circ. Res., January 7, 2005; 96(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
G Eisenhofer, T-T Huynh, K Pacak, F M Brouwers, M M Walther, W M Linehan, P J Munson, M Mannelli, D S Goldstein, and A G Elkahloun
Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome
Endocr. Relat. Cancer, December 1, 2004; 11(4): 897 - 911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Yamakawa, L. X. Liu, A. J. Belanger, T. Date, T. Kuriyama, M. A. Goldberg, S. H. Cheng, R. J. Gregory, and C. Jiang
Expression of angiopoietins in renal epithelial and clear cell carcinoma cells: regulation by hypoxia and participation in angiogenesis
Am J Physiol Renal Physiol, October 1, 2004; 287(4): F649 - F657.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. F. Yang, R. T. Poon, Y. Luo, C. K. Cheung, D. W. Ho, C. M. Lo, and S. T. Fan
Up-Regulation of Vascular Endothelial Growth Factor (VEGF) in Small-for-Size Liver Grafts Enhances Macrophage Activities through VEGF Receptor 2-Dependent Pathway
J. Immunol., August 15, 2004; 173(4): 2507 - 2515.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. J. LEE, C.-H. CHO, S.-J. HWANG, H.-H. CHOI, K.-T. KIM, S. Y. AHN, J.-H. KIM, J.-L. OH, G. M. LEE, and G. Y. KOH
Biological characterization of angiopoietin-3 and angiopoietin-4
FASEB J, August 1, 2004; 18(11): 1200 - 1208.
[Abstract] [Full Text] [PDF]